Key result
Anticoagulant use during radiotherapy for localized prostate cancer was associated with a higher 4-year biochemical control rate compared to no anticoagulants.
Why the study?
Does anticoagulant therapy improve biochemical control in patients with localized prostate cancer treated with radiotherapy?
Cohort (n=662)
Does anticoagulant therapy improve biochemical control in patients with localized prostate cancer treated with radiotherapy?
Anticoagulant therapy is associated with improved biochemical control and reduced distant metastasis in patients with localized prostate cancer receiving curative radiotherapy, particularly in those with high-risk disease.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; hypothesis-generating for anticoagulants enhancing radiotherapy efficacy and requires randomized confirmation.
BACKGROUND: : Substantial experimental evidence suggests that anticoagulants (ACs) may inhibit cancer growth and metastasis, although the limited data from clinical trials have been inconsistent. The potential antineoplastic effect of ACs was investigated in patients who received radiotherapy for localized prostate cancer. METHODS: : The study cohort consisted of 662 patients with adenocarcinoma of the prostate who received radiotherapy (RT) with curative intent. Among those 622 men, 243 (37%) were receiving ACs (warfarin, clopidogrel, and/or aspirin). All patients received external-beam RT, permanent seed implantation, or a combination of both. Prostate-specific antigen (PSA) values were monitored for biochemical control of disease. RESULTS: : At a median follow-up of 49 months, the biochemical control rate at 4-years was significantly better in patients who received ACs at 91% compared with 78% in patients who did not receive ACs (P = .0002). The distant metastasis rate at 4 years also was reduced in the AC group compared with the non-AC group (1% vs 5%; P = .0248). In subgroup analysis, the improvement in biochemical control was significant only for patients with high-risk disease. Along with Gleason score, T classification, and initial PSA, the use of AC therapy was associated independently with improved biochemical control in multivariate analysis. CONCLUSIONS: : AC therapy was associated with an improvement in biochemical control in patients with prostate cancer who received RT with curative intent. The effect was most prominent in patients who had high-risk disease. Cancer 2010.
No takes yet. Share an insight, caveat, or question.
Choe et al. (2010) conducted a cohort in Localized prostate cancer (n=662). Anticoagulants (warfarin, clopidogrel, and/or aspirin) vs. No anticoagulants was evaluated on Biochemical control rate at 4-years (p=0.0002). Anticoagulant use during radiotherapy for localized prostate cancer was associated with a higher 4-year biochemical control rate compared to no anticoagulants.
Synapse has enriched 10 related papers. Consider them for comparative context: